{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:34:31Z","timestamp":1780047271794,"version":"3.53.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9135-17","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T22:09:56Z","timestamp":1512684596000},"page":"537-543","source":"Crossref","is-referenced-by-count":7,"title":["Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis"],"prefix":"10.2169","volume":"57","author":[{"given":"Rieko","family":"Nakatani","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Murata","sequence":"additional","affiliation":[{"name":"Diabetes Center, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Usui","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan"},{"name":"Department of Medical Genetics, Shizuoka General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Moriyoshi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Komeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Masuda","sequence":"additional","affiliation":[{"name":"Diabetes Center, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Kakita-Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tagami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"},{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Imashuku","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine, Uji-Tokushukai Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kono","sequence":"additional","affiliation":[{"name":"Diabetes Center, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Yamada","sequence":"additional","affiliation":[{"name":"Diabetes Center, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"},{"name":"Diabetes Center, National Hospital Organization Kyoto Medical Center, Japan"},{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Practice Guideline for the Treatment for Diabetes in Japan. 2016. 5th ed. The Japan Diabetes Society, Eds. Q2-3 How glycemic goal should be determined? Nankodo, Tokyo, 2016: 27-29 (in Japanese)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A1c in the management of diabetes. J Diabetes 1: 9-17, 2009.","DOI":"10.1111\/j.1753-0407.2009.00009.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Imashuku S, Muramatsu H, Sugihara T, et al. PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus. Int J Hematol 104: 125-129, 2016.","DOI":"10.1007\/s12185-016-1970-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Albuisson J, Jeunemaitre X, Patapoutian A, et al. Dehydrated hereditary stomatocytosis linked to gain-of-function mutations in mechanically activated PIEZO1 ion channels. Nature Commun 4: 1884, 2013.","DOI":"10.1038\/ncomms3440"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translation the A1c assay into estimated average glucose values. Diabetes Care 31: 1473-1478, 2008.","DOI":"10.2337\/dc08-0545"},{"key":"6","unstructured":"6. Gallagher PG, Glader B. Hereditary spherocytosis, hereditary elliptocytosis, and other disorders associated with abnormalities of the erythrocyte membrane. In: Wintrobe&apos;s Clinical Hematology. 13th ed. Greer JP, Arber DA, Glader B, et al., Eds. Wolters Kluwer, Philadelphia, 2014: 707-727."},{"key":"7","unstructured":"7. Utzschneider KM, Kowdley KV. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol 6: 26-33, 2010."},{"key":"8","unstructured":"8. Powell LW. Hemochromatosis. In: Harrison&apos;s Principles of Internal Medicine. 19th ed. Kasper DL, Fauci AS, Longo DL, et al., Eds. McGraw-Hill, New York, 2015: 2514-2519."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. O&apos;keeffe DT, Maraka S, Robert A, Rizza RA. HbA1c in the evaluation of diabetes mellitus. JAMA 315: 605-606, 2016.","DOI":"10.1001\/jama.2015.16561"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 21: 7427-7435, 2015.","DOI":"10.3748\/wjg.v21.i24.7427"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Peters TJ. Ligand binding by albumin. In: All about Albumin-Biochemistry, Genetics, and Medical Applications. Academic Press, San Diego, 1996: 76-132.","DOI":"10.1016\/B978-012552110-9\/50005-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Weiss HM, Fresneau M, Camenisch GP, Kretz O, Gross G. In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670]<sub>2<\/sub> for rat, marmoset, rabbit, mouse, dog, and human. Drug Metab Dispos 34: 971-975, 2006.","DOI":"10.1124\/dmd.105.006429"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bailey TS, Grunberger G, Bode BW, Roberts VL, Rodbard D. American Association of Clinical Endocrinologists and American College of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement. Endocr Pract 22: 231-261, 2016.","DOI":"10.4158\/EP151124.CS"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. American Diabetes Association. Glycemic targets. Diabetes Care 40 (Suppl 1): S48-S56, 2017.","DOI":"10.2337\/dc17-S009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract 104: 1-52, 2014.","DOI":"10.1016\/j.diabres.2012.10.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Japan Diabetes Society\/Japan Geriatrics Society Joint Committee on Improving Care for Elderly Patients with Diabetes. Committee Report: Glycemic targets for elderly patients with diabetes. J Diabetes Investig 8: 126-128, 2017.","DOI":"10.1111\/jdi.12599"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Costa LD, Galimand J, Fenneteau O, Mohandas N. Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev 27: 167-178, 2013.","DOI":"10.1016\/j.blre.2013.04.003"},{"key":"18","unstructured":"18. Yoshida K, Ogawa S. Gentetic analysis of hereditary hematological disorders: overview. Rinsho Ketsueki (Jpn J Clin Hematol) 56: 861-866, 2015 (in Japanese, Abstract in English)."},{"key":"19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ophtha.2010.12.009","volume":"118","author":"M Yasuda","year":"2011","unstructured":"19. Yasuda M, Kiyohara Y, Wang JJ, et al. High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. Ophthalmology 118: 1423-1428, 2011.","journal-title":"Ophthalmology","ISSN":"https:\/\/id.crossref.org\/issn\/0161-6420","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_9135-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:22:02Z","timestamp":1693336922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_9135-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9135-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}